Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hoya ConBio was a prominent manufacturer of medical and dental laser systems, specializing in Q-switched Nd:YAG technology. The company's flagship products, including the MedLite and RevLite laser series, established significant market presence in aesthetic dermatology for applications such as tattoo removal and skin rejuvenation. Additionally, the company produced advanced dental lasers for both hard and soft tissue applications, catering to the evolving needs of dental practitioners. In 2011, Hoya ConBio was acquired by Cynosure for approximately $24.5 million, a move that integrated its specialized laser technologies into a broader aesthetic treatment portfolio. Prior to its acquisition, the company operated as a subsidiary of the Japan-based Hoya Corporation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hoya ConBio.